Artificial intelligence, or AI, was the buzzword of 2023. AI has affected almost every aspect of our world. Although the…
Read More →
Case Name: Janssen Pharms., Inc. v. Tolmar, Inc., Civ. No. 21-1784-WCB, 2024 WL 834762 (D. Del. Feb. 26, 2024) (Bryson,…
Read More →
Based on client inquiries and FDA actions, the Food and Drug Administration is focusing more on companies not submitting data…
Read More →
A plethora of litigation exists in Florida’s state and federal courts regarding the amounts an insurance carrier must reimburse a…
Read More →
On April 27, 2024, Inland Physicians Billing Services (“Inland”) filed a notice of data breach with the U.S. Department of…
Read More →
On May 7, 2024, DocGo, Inc. filed a notice of data breach with the Securities and Exchange Commission after discovering…
Read More →
Several states are considering or have enacted legislation to create prescription drug affordability boards (PDABs)….By: Manatt, Phelps & Phillips, LLP…
Read More →
On April 29, the U.S. Food and Drug Administration (FDA) released a final rule that will gradually phase out FDA’s…
Read More →
FDA’s Final Rule regulating Laboratory-Developed Tests (LDTs) has been published in the Federal Register yesterday, May 6, 2024. This follows a decades-long…
Read More →
The flurry of AI-related activity has certainly begun. Earlier this week, the Department of Commerce’s National Institute of Standards and…
Read More →